Tuberculosis


  • WHO Issues Interim Guidance on the Use of Bedaquiline to Treat MDR-TB
    The World Health Organization (WHO) estimates that up to half a million new cases of multidrug-resistant tuberculosis (MDR-TB) occur worldwide, each year. Current treatment regimens for MDR-TB present many challenges: treatment lasts 20 months or more, requiring daily ...More
    June 17, 2013 Posted in News
  • Tracking Drug-Resistant Tuberculosis in Real Time
    Professor Frances Jamieson at the University of Toronto’s Department of Laboratory Medicine and Pathobiology (LMP), and a medical microbiologist with Public Health Ontario, is leading the way in tracking potentially deadly outbreaks of tuberculosis (TB) with a powerful new ...More
    June 13, 2013 Posted in News
  • Researchers Identify a New Mechanism of TB Drug Resistance
    Pyrazinamide (PZA) -- a frontline tuberculosis (TB) drug -- kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA is used for treating both drug susceptible and multi-drug resistant TB (MDR-TB) but resistance to PZA occurs frequently and ...More
    June 12, 2013 Posted in News
  • Experimental Vaccine Shows Promise Against TB Meningitis
    A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs in TB-infected children and in ...More
    June 12, 2013 Posted in News
  • Targeting High-Risk Neighborhoods May Eliminate Tuberculosis
    Identifying specific neighborhoods that have a high incidence of tuberculosis followed by testing and treating the residents proved to eliminate those communities’ cases of tuberculosis, according to new research published in the American Journal of Public Health. A latent ...More
    May 22, 2013 Posted in News
  • Vitamin D Benefits Breathing in Tuberculosis Patients
    Maintaining adequate levels of vitamin D can help people breathe better and may even protect against tuberculosis (TB), according to a recent study accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). The study of ...More
    March 26, 2013 Posted in News
  • Experts Convene to Report on Progress Toward Tuberculosis Vaccines
    At a time of growing global concern about the rising level of drug-resistant strains of tuberculosis in South Africa and worldwide, the world's top TB vaccine experts are meeting this week, the first time this scientific forum has been held in Africa, where they will ...More
    March 25, 2013 Posted in News
  • World Health Organization Says Funds Needed to Continue Fight Against Tuberculosis
    The World Health Organization (WHO) and the Global Fund to Fight AIDS, TB and Malaria says that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at least $1.6 billion in international funding for treatment and ...More
    March 21, 2013 Posted in News
  • UNITAID and TB Alliance Call for More Action Against Childhood Tuberculosis
    In spite of an estimated 500,000 new annual cases of children with tuberculosis (TB), there are no appropriate medicines for them, UNITAID and the TB Alliance warn. TB, one of the world’s most neglected diseases with almost no new treatments developed in the past 50 years, ...More
    March 19, 2013 Posted in News